Literature DB >> 17236744

Tuberculosis genotyping in six low-incidence States, 2000-2003.

Maryam B Haddad1, Lois A Diem, Lauren S Cowan, M Donald Cave, Juli Bettridge, Lourdes Yun, Carolyn S Winkler, Denise D Ingman, Tanya V Oemig, Allen Lynch, Jose T Montero, Scott B McCombs, Kashef Ijaz.   

Abstract

BACKGROUND: As tuberculosis incidence declines in the United States, a new tool for TB control efforts is Mycobacterium tuberculosis genotyping. Colorado, Iowa, Montana, New Hampshire, West Virginia, and Wisconsin began routine genotyping of all culture-confirmed TB cases in October 2000.
METHODS: M. tuberculosis isolates from cases reported October 2000 through December 2003 were genotyped by spoligotyping, mycobacterial interspersed repetitive units, and IS6110-based restriction fragment length polymorphism methods. Genotyping results were linked to demographic variables from national surveillance records. Patients who were in genotype clusters were interviewed and their records reviewed to determine possible transmission links among clustered patients. Final analysis was completed during April 2004 through June 2005.
RESULTS: Of 971 reported TB cases, 774 (80%) were culture-confirmed, of which 728 (94%) were genotyped. Most genotyped isolates (634 [87%]) were unique. Within 36 clusters linking 94 individuals, four clusters involved both U.S.- and foreign-born individuals. For eight clusters, genotyping results led to the discovery of previously unsuspected transmission. Transmission links between individuals were established in 21 (58%) of the 36 clusters.
CONCLUSIONS: In these six low-incidence states, most isolates had unique genotypes, suggesting that most cases arose from activation of latent infection. Few TB clusters involved the foreign-born. For 58% of genotype clusters, epidemiologic investigation ascertained that clustering represented recent M. tuberculosis transmission.

Entities:  

Mesh:

Year:  2007        PMID: 17236744     DOI: 10.1016/j.amepre.2006.10.013

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  7 in total

1.  Outbreak of tuberculosis among Guatemalan immigrants in rural Minnesota, 2008.

Authors:  Sara A Lowther; Roque Miramontes; Barbara Navara; Nadya Sabuwala; Milayna Brueshaber; Sarah Solarz; Maryam B Haddad; Deborah Sodt; Ruth Lynfield
Journal:  Public Health Rep       Date:  2011 Sep-Oct       Impact factor: 2.792

2.  A tuberculosis outbreak fueled by cross-border travel and illicit substances: Nevada and Arizona.

Authors:  Kiren Mitruka; Haley Blake; Philip Ricks; Roque Miramontes; Sapna Bamrah; Carla Chee; Laurie Hickstein
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

3.  Molecular epidemiology of Mycobacterium tuberculosis in the United States-Affiliated Pacific Islands.

Authors:  Sapna Bamrah; Edward Desmond; Smita Ghosh; Anne Marie France; J Steve Kammerer; Lauren S Cowan; Andrew Heetderks; Alstead Forbes; Patrick K Moonan
Journal:  Asia Pac J Public Health       Date:  2012-12-13       Impact factor: 1.399

4.  Use of tuberculosis genotyping for postoutbreak monitoring.

Authors:  Roque Miramontes; Carla A Winston; Maryam B Haddad; Patrick K Moonan
Journal:  J Public Health Manag Pract       Date:  2012 Jul-Aug

5.  Towards eliminating bias in cluster analysis of TB genotyped data.

Authors:  Cari van Schalkwyk; Madeleine Cule; Alex Welte; Paul van Helden; Gian van der Spuy; Pieter Uys
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

6.  Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the U.S., 2005-2009.

Authors:  Philip M Ricks; Kevin P Cain; John E Oeltmann; J Steve Kammerer; Patrick K Moonan
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240

7.  Whole-Genome Sequencing of Drug-Resistant Mycobacterium tuberculosis Strains, Tunisia, 2012-2016.

Authors:  Imen Bouzouita; Andrea Maurizio Cabibbe; Alberto Trovato; Henda Daroui; Asma Ghariani; Basma Midouni; Leila Essalah; Emna Mehiri; Daniela Maria Cirillo; Leila Slim Saidi
Journal:  Emerg Infect Dis       Date:  2019-03       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.